Sort
141,003 grants matching “cytokine”
METABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIV
$719,829Adrie Jc Steyn · University Of Alabama At Birmingham · R33 · FY2020 · AI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies
$719,801Wilbur A Lam · Emory University · R01 · FY2021 · HL
Determining the Impact of Metabolic Adaptations on the Immune-Tumor Microenvironment in Metastatic Breast Cancer
$719,799Subhamoy Dasgupta · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC
$719,797Eyal Raz · University Of California, San Diego · R01 · FY2022 · HL
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$719,784Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DK
Probing cytosolic nucleic acid sensing pathways in cancer
$719,771Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Control of intestinal innate immunity by the commensal microbiota in a model host
$719,763Paula I Watnick · Boston Children'S Hospital · R01 · FY2021 · AI
The role of ABI3 in Alzheimers disease
$719,698Jungsu Kim · Indiana University Indianapolis · R01 · FY2024 · AG
Controlling Inflammation Due to Cardiac Devices
$719,654Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2011 · HL
The Functional Significance of CTL Escape
$719,626David I Watkins · University Of Miami School Of Medicine · R37 · FY2017 · AI
Targeted suppression of ALDH1A3 for endothelial beneficial management of restenosis after vascular surgery
$719,626Lianwang Guo · University Of Virginia · R01 · FY2025 · HL
Targeted suppression of ALDH1A3 for endothelial beneficial management of restenosis after vascular surgery
$719,626K Craig Kent · University Of Virginia · R01 · FY2024 · HL
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection
$719,615Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
ISLET TOLERANCE INDUCTION BASED ON ANTI-CD154 ANTIBODY
$719,594Univ Of Massachusetts Med Sch Worcester · R01 · FY2000 · DK
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$719,558Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Timing of sodium intake and nocturnal sodium excretion and blood pressure in obese African Americans
$719,496David M Pollock · University Of Alabama At Birmingham · R01 · FY2022 · HL
NAD-dependent Signaling and Pulmonary Vascular Remodeling in PAH
$719,485Roberto F. Machado · Indiana University Indianapolis · R01 · FY2022 · HL
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
$719,445Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Perfused 3D Tissue Surrogates for Complex Cell-Cell Communication Systems
$719,433Linda G. Griffith · Massachusetts Institute Of Technology · R01 · FY2009 · EB
Obesity, Inflammation and Thrombosis: LOOK AHEAD
$719,422Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2008 · HL
Novel Lymphocyte Chemoattractant Receptor and Ligand
$719,405Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2024 · AI
Mechanisms associated with flares and remission in colitis
$719,393Sergio A Lira · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection
$719,391Janice J Endsley · University Of Texas Med Br Galveston · R01 · FY2016 · HL
GENETIC MODIFIERS OF SEVERITY IN SICKLE CELL ANEMIA
$719,353Children'S Hospital Boston · R01 · FY2005 · HL
Identification of the IBD genes on chromosomes 3p and 6p
$719,291Massachusetts Institute Of Technology · R01 · FY2005 · DK